Suplatast Tosilate

甲磺司特

Report date: 2024/12/20 13:57:29
NME

Base Information

Drug NameSuplatast Tosilate
Drug Alias Nametosilato de suplatast托西舒普司特tosilate de suplatastSuplatast tosylatesuplatasti tosilas +[9] 
ClassificationSmall molecules
Mechanisms of ActionTh2 cells inhibitors
TargetsNot applicable
Therapy Area/IndicationsHypersensitivityDermatitis, AtopicRhinitis, Allergic +[4] 
Global Approved IndicationsHypersensitivityDermatitis, AtopicRhinitis, Allergic +[4] 
Approved Indications in ChinaHypersensitivityAsthma
Original Approved Country/TerritoryJapan
Original Approved Date1995/04/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesTaiho Pharmaceutical Co LtdZein Bioteccnology Co Ltd
Inactive CompaniesN/A
Active IndicationsHypersensitivityDermatitis, AtopicRhinitis, Allergic +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeR
Related LinksWikipediaKEGG